Semaglutide – 20mg

GLP-1 Receptor Agonist for Weight Regulation & Metabolic Studies | From Peptide Research Hub

What is Semaglutide?

Semaglutide is a long-acting GLP-1 receptor agonist that mimics the action of the human incretin hormone glucagon-like peptide-1 (GLP-1). Originally developed to support insulin regulation, it has become a popular candidate for research focused on appetite suppression, weight loss, and type 2 diabetes models.

The 20mg format provides a higher-yield vial suitable for extended laboratory trials or comparative metabolic studies in larger models or cell groups.

Reference: Wikipedia – Semaglutide

Mechanism of Action

Semaglutide binds to GLP-1 receptors in the pancreas and central nervous system, enhancing insulin secretion while reducing glucagon levels and delaying gastric emptying. These mechanisms help promote satiety and regulate appetite—making it an ideal candidate for research related to obesity and metabolic disorders.

Unlike short-acting GLP-1 peptides, semaglutide’s half-life allows for prolonged receptor engagement and sustained metabolic effects in preclinical models.

Semaglutide Research Applications

• Appetite suppression and satiety mechanisms
• Insulin regulation and glucose control
• Obesity and metabolic syndrome models
• GLP-1 receptor pathway analysis
• Body composition and caloric intake studies
• Type 2 diabetes research models

Why Choose PRH?

• High-purity (≥99%) lyophilized peptides
• Manufactured in the U.S. under sterile lab conditions
• Fast shipping and responsive customer support
• Over 15 years of experience in research peptide sourcing

Product Specifications

• Compound: Semaglutide
• Concentration: 20mg per vial
• Form: Lyophilized powder
• Purity: ≥99% (HPLC-verified)
• Appearance: White to off-white powder
• Storage: -20°C; refrigerate after reconstitution
• Solvent: Bacteriostatic water recommended

Disclaimer: This compound is intended for research and laboratory use only. Not for human or veterinary use.